Sarcoidosis requiring systemic treatment: why not a steroid-sparing regimen up-front?
Nadera Sweiss(University of Illinois Chicago), Henry Yeager(University of Maryland, Baltimore)
PubMed
July 1, 2010
Cited by 5
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Racial Difference in Sarcoidosis Mortality in the United States
|CHEST Journal|2014|251
Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction
|Circulation Cardiovascular Imaging|2016|217